Friedrich R J, Campbell K S, Cambier J C
National Jewish Center for Immunology and Respiratory Medicine, Department of Pediatrics, Denver, CO 80206.
J Immunol. 1993 Apr 1;150(7):2814-22.
The predominant Ag-receptor complex of B cells consists of mIgM or mIgD noncovalently associated with glycosylated heterodimers of Ig-alpha and Ig-beta or Ig-alpha and Ig-gamma. Upon B cell stimulation the associated proteins are phosphorylated, giving rise to pp32/33 (alpha), pp37 (beta), and pp34 (previously designated gamma). Ig-alpha and Ig-beta contain extended cytoplasmic structure (61 and 48 amino acids, respectively) and associate with cytoplasmic effectors indicating that they are directly involved in signal transduction. Here we report analysis of the structural relationship of mIgM- and mIgD-associated Ig-beta and Ig-gamma chains from mice. N-terminal sequence, immunoblotting, and physicochemical analyses show that both Ig-beta and Ig-gamma are products of the B cell-specific B29 gene and demonstrate that the 37-kDa Ig-beta protein is the full length predicted product of the B29 gene. The Ig-associated protein that migrates in the 34-kDa range is actually two distinct species. The minor species is a phosphorylatable and underglycosylated form of full length Ig-beta, and the major species is a C-terminally truncated form of B29, which we now designate Ig-gamma. This conclusion is based on the observations that Ig-gamma is composed of a core protein which is 3 to 4 kDa smaller than deglycosylated Ig-beta, it is not phosphorylated, unlike Ig-beta, and it does not react with an antiserum raised against a peptide of the seven C-terminal amino acids of B29. Based on these findings we estimate that Ig-gamma is truncated by about 30 to 36 amino acid residues and hypothesize that the most 3' B29 exon, which encodes the 32 C-terminal residues, may not be expressed in Ig-gamma. All of the documented B29 products are found in association with both mIgM and mIgD. Interestingly, Ig-gamma is found in intermediate and low density splenic B cells, but is not detectable in resting B cells. This raises the possibility that it may confer some distinct signaling function on the Ag receptors of these cells.
B细胞主要的抗原受体复合物由与Ig-α和Ig-β或Ig-α和Ig-γ的糖基化异二聚体非共价结合的mIgM或mIgD组成。在B细胞受到刺激时,相关蛋白会发生磷酸化,产生pp32/33(α)、pp37(β)和pp34(先前称为γ)。Ig-α和Ig-β含有延伸的细胞质结构(分别为61和48个氨基酸),并与细胞质效应分子结合,表明它们直接参与信号转导。在此,我们报告了对小鼠mIgM和mIgD相关的Ig-β和Ig-γ链结构关系的分析。N端序列、免疫印迹和物理化学分析表明,Ig-β和Ig-γ都是B细胞特异性B29基因的产物,并证明37 kDa的Ig-β蛋白是B29基因预测的全长产物。在34 kDa范围内迁移的Ig相关蛋白实际上是两种不同的物种。次要物种是全长Ig-β的可磷酸化和低糖基化形式,主要物种是B29的C端截短形式,我们现在将其命名为Ig-γ。这一结论基于以下观察结果:Ig-γ由一种核心蛋白组成,该核心蛋白比去糖基化的Ig-β小3至4 kDa,它不像Ig-β那样被磷酸化,并且它不与针对B29七个C端氨基酸的肽产生的抗血清发生反应。基于这些发现,我们估计Ig-γ被截短了约30至36个氨基酸残基,并推测编码32个C端残基的最3'端B29外显子可能在Ig-γ中不表达。所有已记录的B29产物都与mIgM和mIgD相关。有趣的是,Ig-γ存在于中等密度和低密度的脾脏B细胞中,但在静息B细胞中无法检测到。这增加了它可能赋予这些细胞的抗原受体一些独特信号功能的可能性。